Divis Laboratories (DIVISLAB), currently trading at Rs.6,623 with a modest 0.4% gain today, is a prominent pharma stock held by numerous mutual funds across different categories. Understanding which mutual funds hold Divis Laboratories is crucial for retail investors running SIPs, as it helps identify portfolio overlap, assess fund manager conviction, and avoid overexposure to a single stock. This comprehensive analysis reveals the types of funds holding DIVISLAB, their weightages, and how you can use this data to make smarter investment decisions.
| Parameter | Value |
|---|---|
| Current Price | Rs.6,623 |
| Day High/Low | Rs.6,636.5 / Rs.6,567 |
| 52-Week High/Low | Rs.7,071.5 / Rs.5,636.5 |
| Today’s Volume | 200,963 shares |
| Sector | Pharmaceuticals |
| Distance from 52W High | -6.3% |
Why Knowing Your MF Exposure to Divis Laboratories Matters
Most SIP investors run multiple mutual fund schemes simultaneously without tracking individual stock holdings. Consequently, you might unknowingly hold the same stock across four or five different funds. This creates concentration risk rather than diversification.
For instance, if you invest in a Nifty 50 index fund, a healthcare sector fund, and a large-cap active fund, all three likely hold Divis Laboratories. Moreover, your mid-cap fund might also include DIVISLAB given its market positioning. Therefore, your actual exposure becomes far higher than intended.
Understanding which mutual funds hold Divis Laboratories helps you rebalance effectively. Additionally, it prevents unnecessary portfolio overlap. Furthermore, it allows you to assess whether your investment strategy aligns with your risk appetite.
Types of Funds That Typically Hold Divis Laboratories
Divis Laboratories appears in multiple mutual fund categories based on its market capitalization and sectoral classification. Index funds mandatorily include it based on benchmark composition. Active fund managers add it based on conviction and growth prospects.
Pharma-focused sector funds naturally hold significant positions in DIVISLAB. Meanwhile, flexi-cap and multi-cap funds include it as a quality pharma play. Large-cap funds frequently feature it among top holdings given its established market position.
| Fund Category | Typical DIVISLAB Holding Pattern | Why They Hold It |
|---|---|---|
| Nifty 50 Index Funds | 0.8-1.2% weightage | Mandatory index constituent replication |
| Pharma Sector Funds | 5-12% weightage | Leading API manufacturer with export strength |
| Large Cap Funds | 1-3% weightage | Quality pharma exposure with strong margins |
| Flexi-cap Funds | 0.5-2.5% weightage | Flexibility to overweight based on opportunities |
| Multi-cap Funds | 1-2% weightage | Diversified portfolio with pharma allocation |
| ELSS Funds | 0.5-2% weightage | Tax-saving with long-term growth potential |
Nifty and Sensex Index Fund Weightage
Divis Laboratories is a constituent of the Nifty 50 and Nifty Pharma indices. Therefore, all index funds tracking these benchmarks automatically hold DIVISLAB shares. The weightage varies based on the company’s market capitalization and free-float adjustment.
In Nifty 50 index funds, DIVISLAB typically carries a weightage around 1%. However, in Nifty Pharma index funds, this weightage jumps substantially to 8-15%. Consequently, investors holding both types of index funds inadvertently increase their Divis exposure.
Index fund holdings are non-negotiable and rebalance automatically. As a result, when DIVISLAB’s market cap changes, your exposure adjusts proportionately. This passive approach eliminates fund manager bias but reduces customization flexibility.
Active Fund Manager Conviction Explained
Active fund managers demonstrate conviction through their allocation percentages. When a fund holds DIVISLAB at 3% while the benchmark weightage is 1%, it signals strong positive conviction. Conversely, underweight positions indicate caution or preference for other opportunities.
Several pharma-focused active funds maintain overweight positions in Divis Laboratories. Furthermore, quality-focused funds appreciate its superior EBITDA margins and export revenue consistency. Therefore, high conviction positions often range between 3-5% in concentrated portfolios.
Tracking changes in fund manager holdings provides valuable insights. Moreover, consistent holding over multiple quarters indicates sustained confidence. In contrast, gradual reduction might signal changing sector dynamics or valuation concerns.
How to Check If Your SIP Holds Divis Laboratories
Checking whether your SIP mutual funds hold Divis Laboratories requires examining monthly portfolio disclosures. Fund houses publish complete holdings on their websites and through AMFI portals. Additionally, several investment platforms aggregate this data for easy comparison.
Follow these simple steps to verify your DIVISLAB exposure:
- Visit the fund house website: Download the latest monthly portfolio statement from the specific scheme page.
- Check AMFI website: Access standardized portfolio disclosures updated monthly for all mutual fund schemes.
- Use investment apps: Platforms like Kuvera, Groww, and Zerodha Coin show individual stock holdings within each scheme.
- Review consolidated reports: Most investment apps provide portfolio overlap analysis highlighting common stock holdings.
- Calculate total exposure: Add up DIVISLAB holdings across all your schemes to determine aggregate exposure percentage.
Regular monitoring helps maintain desired diversification levels. Therefore, quarterly reviews are recommended for active SIP investors. Furthermore, this practice prevents unintended concentration in single stocks.